Literature DB >> 3813932

Ischemia may be the primary cause of the neurologic deficits in classic migraine.

T Skyhøj Olsen, L Friberg, N A Lassen.   

Abstract

This study investigates whether the cerebral blood flow reduction occurring in attacks of classic migraine is sufficient to cause neurologic deficits. Regional cerebral blood flow measured with the xenon 133 intracarotid injection technique was analyzed in 11 patients in whom a low-flow area developed during attacks of classic migraine. When measured with this technique, regional cerebral blood flow in focal low-flow areas will be overestimated because of the effect of scattered radiation (Compton scatter) on the recordings. In this study, this effect was particularly taken into account when evaluating the degree of blood flow reduction. During attacks of classic migraine, cerebral blood flow reductions averaging 52% were observed focally in the 11 patients. Cerebral blood flow levels known to be insufficient for normal cortical function (less than 16 to 23 mL/100 g/min) were measured in seven patients during the attacks. This was probably also the case in the remaining four patients, but the effect of scattered radiation made a reliable evaluation of blood flow impossible. It is concluded that the blood flow reduction that occurs during attacks of classic migraine is sufficient to cause ischemia and neurologic deficits. Hence, this study suggests a vascular origin of the prodromal neurologic deficits that may accompany attacks of classic migraine.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3813932     DOI: 10.1001/archneur.1987.00520140028013

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  10 in total

1.  Long term decline of P100 amplitude in migraine with aura.

Authors:  N M Khalil; N J Legg; D J Anderson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-10       Impact factor: 10.154

Review 2.  Cerebral blood flow changes in migraine: methods, observations and hypotheses.

Authors:  L Friberg
Journal:  J Neurol       Date:  1991       Impact factor: 4.849

3.  Migraine as a defect of brain oxidative metabolism: a hypothesis.

Authors:  P Montagna; T Sacquegna; P Cortelli; E Lugaresi
Journal:  J Neurol       Date:  1989-02       Impact factor: 4.849

Review 4.  Spreading Depression, Spreading Depolarizations, and the Cerebral Vasculature.

Authors:  Cenk Ayata; Martin Lauritzen
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

5.  Mechanisms of migraine aura revealed by functional MRI in human visual cortex.

Authors:  N Hadjikhani; M Sanchez Del Rio; O Wu; D Schwartz; D Bakker; B Fischl; K K Kwong; F M Cutrer; B R Rosen; R B Tootell; A G Sorensen; M A Moskowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-03       Impact factor: 11.205

6.  Cerebral infarcts associated with migraine: clinical features, risk factors and follow-up.

Authors:  R A Hoekstra-van Dalen; J P Cillessen; L J Kappelle; J van Gijn
Journal:  J Neurol       Date:  1996-07       Impact factor: 4.849

7.  [Clinical aspects of pathophysiological mechanisms in migraine.].

Authors:  K H Grotemeyer; I W Husstedt; H P Schlake
Journal:  Schmerz       Date:  1989-12       Impact factor: 1.107

Review 8.  Immunologic aspects of migraine: A review of literature.

Authors:  Mehrnaz Salahi; Sina Parsa; Delaram Nourmohammadi; Zahra Razmkhah; Omid Salimi; Mohammadreza Rahmani; Saeid Zivary; Monireh Askarzadeh; Mohammad Amin Tapak; Ali Vaezi; Hamidreza Sadeghsalehi; Shirin Yaghoobpoor; Mehran Mottahedi; Setareh Garousi; Niloofar Deravi
Journal:  Front Neurol       Date:  2022-09-28       Impact factor: 4.086

9.  Interictal dysfunction of a brainstem descending modulatory center in migraine patients.

Authors:  Eric A Moulton; Rami Burstein; Shannon Tully; Richard Hargreaves; Lino Becerra; David Borsook
Journal:  PLoS One       Date:  2008-11-24       Impact factor: 3.240

10.  Risk of Stroke in Migraineurs Using Triptans. Associations with Age, Sex, Stroke Severity and Subtype.

Authors:  Vanna Albieri; Tom Skyhøj Olsen; Klaus Kaae Andersen
Journal:  EBioMedicine       Date:  2016-02-27       Impact factor: 8.143

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.